Purpose: To evaluate the efficacy of laser photocoagulation and injection AntiVEGF in central serous
chorioretinopathy in combined military hospital.
Method: 28 cases of central serous chorioretinopathy presented to in eye department of Combined
Military Hospital from September 2022 to September 2023. These cases were diagnosed clinically and
confirmed by fundus fluorescence angiogram and optical coherence tomography. After thorough
evaluation, Focal laser was perform in 16 indicated cases and intravitreal AntiVEGF (Bebacizumab)
were given 4 cases of subfoveal leak central serous chorioretinopathy after 3 month observation. Post
intervention follow up schedule were 1 week, 1 month and 3 months. The main features evaluated are
presenting best corrected visual acuity, associated findings and best corrected visual acuity and
complications after laser or AntiVEGF injection. Other data includes age, gender, laterality of eyes,
risk factors; types of leaking were also recorded.
Result: Out of 28 cases, 7 cases were central serous chorioretinopathy with subfoveal leak in
angiogram. Among those, 10 cases were presented with central serous chorioretinopathy with pigment
epithelial detachment. After 3 months of follow up, subretinal fluid was disappear in 14 cases out of 16
cases of laser. Spontaneous resolution occurred in 8 cases. One patient was presented with RPE
tracking. Age limit were extent from 22 years to 48 years, most of them were in third decade.
Conclusion: Central serous chorioretinopathy most commonly present without any specific cause. Due
to professional demand, most of the causes need intervention which gives fruitful outcome of
improvement of visual acuity with reduced subjective contrast.